Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.

Journal article

Murray SM. et al, (2023), Nat Rev Immunol, 23, 304 - 316

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy

Journal article

Downs LO. et al, (2023), PLOS Global Public Health, 3, e0001165 - e0001165

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117.

Journal article

Zacharopoulou P. et al, (2022), Curr Opin HIV AIDS, 17, 352 - 358

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.

Journal article

Ogbe A. et al, (2022), JCI Insight, 7

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Journal article

Tomic A. et al, (2022), Nat Commun, 13

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

Journal article

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

Load More